CLSI eNews - 1 August 2007 (Plain Text Version)

Return to Graphical Version | Search back issues | Print all articles

In this issue:
Note on printing single articles: Each selected individual article will appear at the bottom of this screen...please scroll down to view/print the selected article.

News
Executive Vice President's Message
CLSI President-Elect to Meet With JCCLS in Tokyo
CLSI's The Key to Quality
Lois Schmidt, DA Appointed CLSI’s Vice President of Standards
James Nichols, PhD, DABCC, FACB To Serve as CLSI’s Editorial Review Board Representative for Lab Tests Online
Honoring the Life and Accomplishments of Richard R. Miller, Jr.
Recent Changes to CLSI Membership Categories
Press Releases
Standards Status
Vote and Deadlines
Recently Approved Documents
Recently Distributed ISO Standard
Call for Nominations
Events and Exhibits
Upcoming Events
Upcoming Presentations
CLSI Meetings Calendar
Participate in CLSI
Volunteer
New and Sustaining Members
Update Your Subscription

Press Releases

Newborn Screening Specimen Collection (LA4-A5); Verification and Validation of Multiplex Nucleic Acid Assays (MM17-P)

CLSI Publishes Standard for Newborn Screening Specimen Collection
Wayne, Pennsylvania, USA—August 2007— In all newborn screening programs, the turnaround time for analytic results is critical for prompt diagnosis and treatment. The new edition of Clinical and Laboratory Standards Institute’s (CLSI) document titled Blood Collection on Filter Paper for Newborn Screening Programs; Approved Standard—Fifth Edition (LA4-A5) addresses the issues associated with specimen collection, the filter paper collection device, and the transfer of blood onto filter paper, and provides uniform techniques for collecting the best possible specimen for use in newborn screening programs.
Read full press release.

New CLSI Guideline Provides Protocols for Verification and Validation of Multiplex Nucleic Acid Assays
Wayne, Pennsylvania, USA—August 2007—Multiplex assays detect the presence of and discriminate two or more analytes simultaneously in the same sample. The number of commercially available multiplex assays is increasing rapidly, as is the number of laboratory-developed multiplex assays, and these use a variety of technologies and instrument platforms. Multiplex testing provides significant challenges to the laboratory with regards to appropriate verification and validation testing, and especially the acquisition of appropriate control and reference materials to conduct the testing.

Clinical and Laboratory Standards Institute (CLSI) has recently published a new document, Verification and Validation of Multiplex Nucleic Acid Assays; Proposed Guideline (MM17-P), which provides recommendations for analytic verification and validation of multiplex assays, as well as a review of different types of biologic and synthetic reference materials.
Read full press release.